Innovating Works
Mostrando 1 al 20 de 325 resultados
RESPIRE-EXCEL: Respiratory Precision Medicine PhD Training Network- Excellence through Systems Biology, Spatial and... ACADEMISCH ZIEKENHUIS GRONINGEN tramitó un HORIZON EUROPE: HORIZON-MSCA-2023-DN-01 Asthma and COPD are prevalent, chronic respiratory diseases, with high incidence and societal costs. Current treatment is based on a ‘one-si...
2025-03-01 - 2029-02-28 | Financiado
ELIMINATE-CKD: Early detection, molecular mechanisms and therapeutic interventions in chronic kidney disease ACADEMISCH ZIEKENHUIS GRONINGEN tramitó un HORIZON EUROPE: ERC-2023-COG The objective of ELIMINATE-CKD is to demonstrate that combining measures of kidney structure and function will strongly enhance detection of...
2024-09-01 - 2029-08-31 | Financiado
MAP-ID: Multilevel approaches to understanding chronic inflammatory diseases. The MAP-ID project aims to deliver an East-West Europe-integrating training programme for PhD students, focused on tackling one of the most...
2024-08-29 - 2030-03-31 | Financiado
ERDERA: EUROPEAN RARE DISEASES RESEARCH ALLIANCE ACADEMISCH ZIEKENHUIS GRONINGEN participó en un HORIZON EUROPE: HORIZON-HLTH-2023-DISEASE-07 The European Rare Diseases Research Alliance (ERDERA) aims to improve the health and well-being of the 30 million people living with a rare...
2024-08-20 - 2031-08-31 | Financiado
ELIMINATE-CKD: Early detection molecular mechanisms and therapeutic interventions in chronic kidney disease ACADEMISCH ZIEKENHUIS GRONINGEN tramitó un HORIZON EUROPE: ERC-2023-COG The objective of ELIMINATE-CKD is to demonstrate that combining measures of kidney structure and function will strongly enhance detection of...
2024-07-10 - 2029-08-31 | Financiado
VoCS: Voice Communication Sciences With AI-driven advances, the rapidly developing field of voice technology (VT) has transformed European life through voice assistants, text-...
2024-07-10 - 2028-11-30 | Financiado
RESPIRE-EXCEL: Respiratory Precision Medicine PhD Training Network Excellence through Systems Biology Spatial and... ACADEMISCH ZIEKENHUIS GRONINGEN tramitó un HORIZON EUROPE: HORIZON-MSCA-2023-DN-01 Asthma and COPD are prevalent, chronic respiratory diseases, with high incidence and societal costs. Current treatment is based on a ‘one-si...
2024-07-01 - 2029-02-28 | Financiado
DELTA-LANG: The Delta of Language ACADEMISCH ZIEKENHUIS GRONINGEN tramitó un HORIZON EUROPE: ERC-2023-SyG Mental life fluctuates, changing from moment to moment as the incessant and turbulent flow of thought rages. In 3% of the world’s population...
2024-06-01 - 2030-05-31 | Financiado
MyoNanoCell: MyoNanoCell: CardioMYOgenic NANOsized CELL-based Vehicles for Cardiac Microenvironment Modulation an... ACADEMISCH ZIEKENHUIS GRONINGEN tramitó un HORIZON EUROPE: HORIZON-MSCA-2023-PF-01 Cardiovascular diseases are the leading cause of death worldwide, accounting roughly for 45% of all deaths in Europe and costing billions of...
2024-05-08 - 2027-08-31 | Financiado
SAVETHEHEART: Microfluidics-assisted synthesis of Dapagliflozin-loaded liposomes for heart fibrosis: Development o... ACADEMISCH ZIEKENHUIS GRONINGEN tramitó un HORIZON EUROPE: HORIZON-MSCA-2023-PF-01 Cardiovascular diseases (CVDs) are the leading cause of death worldwide, with half of CVDs deaths being caused by coronary artery disease. M...
2024-03-07 - 2026-09-14 | Financiado
PROVIDE: Patient-centered care for vestibular disorders ACADEMISCH ZIEKENHUIS GRONINGEN tramitó un HORIZON EUROPE: HORIZON-MSCA-2022-DN-01 Despite receiving little attention, vestibular disorders result in loss of vestibular (inner ear) function and create costly health disparit...
2024-02-01 - 2028-01-31 | Financiado
PsyPal: Psilocybin Therapy for Psychological Distress in Palliative Care Patients ACADEMISCH ZIEKENHUIS GRONINGEN tramitó un HORIZON EUROPE: HORIZON-HLTH-2023-DISEASE-03 Relieving serious health-related suffering for patients in palliative and end-of-life care, be it physical, psychological, social, or spirit...
2024-01-01 - 2027-12-31 | Financiado
DRAIGON: Diagnosing Infections with Multi-Drug Resistant Microorganisms using AI-powered Genomic Antibiotic S... ACADEMISCH ZIEKENHUIS GRONINGEN participó en un HORIZON EUROPE: HORIZON-HLTH-2023-TOOL-05 The silent pandemic of antimicrobial resistance (AMR) is a growing global health crisis with a projected annual mortality rate of 10 million...
2023-12-13 - 2027-12-31 | Financiado
ERAMET: Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the... ACADEMISCH ZIEKENHUIS GRONINGEN participó en un HORIZON EUROPE: HORIZON-HLTH-2023-IND-06 ERAMET will provide an integrated approach for developers and regulators’ decision-making for paediatric and orphan drugs, centred on the dr...
2023-11-17 - 2027-12-31 | Financiado
NuCapCure: Development of innovative proton and neutron therapies with high cancer specificity by 'hijacking' t... ACADEMISCH ZIEKENHUIS GRONINGEN participó en un HORIZON EUROPE: HORIZON-EIC-2023-PATHFINDEROPEN-01 "Deep-lying cancers, such as glioblastoma multiforme (GBM) brain cancer, are very difficult to access and incurable by the current standards...
2023-11-16 - 2028-07-31 | Financiado
ArTCell: Bottom-up manufacturing of artificial anti-tumor T cells ACADEMISCH ZIEKENHUIS GRONINGEN participó en un HORIZON EUROPE: HORIZON-EIC-2023-PATHFINDEROPEN-01 T cells play a central role in anti-tumor immune protection. While their ability to target and eliminate emerging tumor cells is increasingl...
2023-10-09 - 2029-01-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.